Skip to main content
Veterinary Medicines

Ophtocycline 10mg/g eye ointment for horses, dogs and cats

Authorised
  • CHLORTETRACYCLINE HYDROCHLORIDE

Product identification

Medicine name:
Ophtocycline 10mg/g eye ointment for horses, dogs and cats
Ophtocycline 10 mg/g očná masť pre psy, mačky a kone
Active substance:
  • CHLORTETRACYCLINE HYDROCHLORIDE
Target species:
  • Horse
  • Dog
  • Cat
Route of administration:
  • Ocular use

Product details

Active substance and strength:
  • CHLORTETRACYCLINE HYDROCHLORIDE
    10.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Eye ointment
Withdrawal period by route of administration:
  • Ocular use
    • Horse
      • Meat and offal
        1
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS01AA02
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:
  • Epoxy resin lacquered aluminium tube with a content of 5 g, with a HDPE cannula and screw cap. One tube in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/043/DC/17-S
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0209/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."